GlassScriptPhysician profile
Vipin Garg
NPI 1881662062
$6,144.49
in general payments reported to CMS, 2019-2025
39 companies · $1,435 in 2025
The $1,435 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $401 · 2021: $821 · 2022: $872 · 2023: $903 · 2024: $1,059 · 2025: $1,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,309 · Education: $87.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,309.12 |
| Education | $87.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,428.66 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $736.16 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $690.00 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $582.09 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Genzyme Corporation | $307.49 | 2019-2025 | |
| Insmed, INC. | $237.35 | 2024-2025 | Arikayce, Brinsupri |
| Abbott Laboratories | $223.19 | 2024-2025 | Amplatzer Amulet, Aveir |
| Harmony Biosciences LLC | $208.72 | 2023-2025 | Wakix |
| Philips North America LLC | $186.37 | 2019-2024 | (Ak6) Vest Therapy |
| Medtronic, INC. | $152.05 | 2025 | Aurora Ev-Icd Mri Surescan |
| Itamar Medical INC | $114.13 | 2024 | Watchpatone |
| Ani Pharmaceuticals, INC. | $113.21 | 2022-2025 | Purified Cortrophin Gel |
| United Therapeutics Corporation | $109.32 | 2021-2025 | Tyvaso, Tyvaso |
| Sunovion Pharmaceuticals INC. | $108.16 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $98.52 | 2019-2023 | Belsomra |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vipin Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.